113 related articles for article (PubMed ID: 11267100)
1. Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury.
Chen W; Bennett CF; Condon TP; Stecker K; Tian L; Kahan BD; Stepkowski SM
Transplant Proc; 2001; 33(1-2):854. PubMed ID: 11267100
[No Abstract] [Full Text] [Related]
2. Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury.
Stepkowski SM; Chen W; Bennett CF; Condon TP; Stecker K; Tian L; Kahan BD
Transplant Proc; 2001; 33(7-8):3705-6. PubMed ID: 11750578
[No Abstract] [Full Text] [Related]
3. Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicity.
Chen W; Langer RM; Janczewska S; Furian L; Geary R; Qu X; Wang M; Verani R; Condon T; Stecker K; Bennett CF; Stepkowski SM
Transplantation; 2005 Feb; 79(4):401-8. PubMed ID: 15729165
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat.
Haller H; Dragun D; Miethke A; Park JK; Weis A; Lippoldt A; Gross V; Luft FC
Kidney Int; 1996 Aug; 50(2):473-80. PubMed ID: 8840275
[TBL] [Abstract][Full Text] [Related]
5. Perfusion of kidneys with unformulated "naked" intercellular adhesion molecule-1 antisense oligodeoxynucleotides prevents ischemic/reperfusion injury.
Chen W; Bennett CF; Wang ME; Dragun D; Tian L; Stecker K; Clark JH; Kahan BD; Stepkowski SM
Transplantation; 1999 Sep; 68(6):880-7. PubMed ID: 10515390
[TBL] [Abstract][Full Text] [Related]
6. Diapedesis of leukocytes: antisense oligonucleotides for rescue.
Dragun D; Haller H
Exp Nephrol; 1999; 7(2):185-92. PubMed ID: 10213872
[TBL] [Abstract][Full Text] [Related]
7. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation.
Dragun D; Tullius SG; Park JK; Maasch C; Lukitsch I; Lippoldt A; Gross V; Luft FC; Haller H
Kidney Int; 1998 Aug; 54(2):590-602. PubMed ID: 9690227
[TBL] [Abstract][Full Text] [Related]
8. Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides.
Ortiz AM; Troncoso P; Kahan BD
Transplant Proc; 2003 Jun; 35(4):1571-4. PubMed ID: 12826223
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat.
Dragun D; Lukitsch I; Tullius SG; Qun Y; Park JK; Schneider W; Luft FC; Haller H
Kidney Int; 1998 Dec; 54(6):2113-22. PubMed ID: 9853277
[TBL] [Abstract][Full Text] [Related]
10. Development of antisense oligodeoxynucleotides for transplantation.
Stepkowski SM
Curr Opin Mol Ther; 2000 Jun; 2(3):304-17. PubMed ID: 11249625
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is neuroprotective after transient middle cerebral artery occlusion in rat.
Vemuganti R; Dempsey RJ; Bowen KK
Stroke; 2004 Jan; 35(1):179-84. PubMed ID: 14657453
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury.
Matsuyama M; Yoshimura R; Akioka K; Okamoto M; Ushigome H; Kadotani Y; Nakatani T; Yoshimura N
Transplantation; 2003 Sep; 76(5):786-91. PubMed ID: 14501854
[TBL] [Abstract][Full Text] [Related]
13. Use of FTY 720 and ICAM-1 antisense oligonucleotides for attenuating chronic renal damage secondary to ischemia-reperfusion injury.
Troncoso P; Ortiz AM; DomÃnguez J; Kahan BD
Transplant Proc; 2005 Dec; 37(10):4284-8. PubMed ID: 16387098
[TBL] [Abstract][Full Text] [Related]
14. ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease.
Rijcken E; Krieglstein CF; Anthoni C; Laukoetter MG; Mennigen R; Spiegel HU; Senninger N; Bennett CF; Schuermann G
Gut; 2002 Oct; 51(4):529-35. PubMed ID: 12235075
[TBL] [Abstract][Full Text] [Related]
15. Antisense ICAM-1 oligonucleotides block allograft rejection in rats.
Stepkowski SM; Wang ME; Amante A; Kalinin D; Qu X; Blasdel T; Condon T; Kahan BD; Bennett FC
Transplant Proc; 1997; 29(1-2):1285. PubMed ID: 9123308
[No Abstract] [Full Text] [Related]
16. Development of an oral formulation for ICAM-1 antisense oligonucleotides.
Stepkowski SM; Chen W; Geary R; Wang ME; Condon T; Stecker K; Bennett CF
Transplant Proc; 2001; 33(1-2):387. PubMed ID: 11266874
[No Abstract] [Full Text] [Related]
17. Inhibition of ICAM-1 gene expression by antisense 2',4'-BNA oligonucleotides.
Obika S; Hemamayi R; Masuda T; Sugimoto T; Nakagawa S; Mayumi T; Imanishi T
Nucleic Acids Res Suppl; 2001; (1):145-6. PubMed ID: 12836306
[TBL] [Abstract][Full Text] [Related]
18. Antisense intercellular adhesion molecule-1 (ICAM-1) oligodeoxyribonucleotide delivered during organ preservation inhibits posttransplant ICAM-1 expression and reduces primary lung isograft failure.
Toda K; Kayano K; Karimova A; Naka Y; Fujita T; Minamoto K; Wang CY; Pinsky DJ
Circ Res; 2000 Feb; 86(2):166-74. PubMed ID: 10666412
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
Ghobrial R; Amersi F; Stecker K; Kato H; Melinek J; Singer J; Mhoyan A; Busuttil RW; Kupiec-Weglinski JW; Stepkowski SM
Transplant Proc; 2001; 33(1-2):538. PubMed ID: 11266946
[No Abstract] [Full Text] [Related]
20. Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
Stepkowski SM; Wang ME; Condon TP; Cheng-Flournoy S; Stecker K; Graham M; Qu X; Tian L; Chen W; Kahan BD; Bennett CF
Transplantation; 1998 Sep; 66(6):699-707. PubMed ID: 9771832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
